Resolve Biosciences
Spatially Resolved Transcriptomics Early Access Grant
Apply for one of two Molecular CartographyTM RNA Profiling projects
between February 7 – March 7, 2022
What is the Spatially Resolved Transcriptomics Early Access Grant?
Nature declared spatially resolved transcriptomics 2020 Method of the year. Without a doubt this emerging field is going to play a major role in transforming our understanding of systems biology. This powerful method will impact your research by providing answers to scientific questions previously left unanswered. Therefore, as an associated partner of the Virchow 2.0 innovation cluster, Resolve Biosciences will award two Molecular Cartography RNA profiling grants, of 8 samples each, to scientists from Virchow 2.0 core partner institutions - the Max Delbrück Center for Molecular Medicine (MDC) including the Berlin Institute for Medical Systems Biology (BIMSB), the Charité – Universitätsmedizin Berlin, including the Berlin Institute of Health (BIH) - who propose projects that can advance their field of study. Grant awards will be selected based on technical feasibility and the potential to accelerate a specific area of research.
What is Molecular CartographyTM?
This pioneering platform produces deep contextual data sets that illuminate molecular interactions at subcellular resolution while maintaining tissue integrity. Molecular Cartography interrogates RNA transcript activity from 100 genes of your choice per sample run, with each slide suitable for up to 8 samples. Click here to download information demonstrating the utility of spatial genomics.
Application
Notification of award March 18th, 2022
Which species and tissue types can be used?
| Species | Tissue | Condition |
|---|---|---|
| Mouse | Brain - Liver | Fresh frozen non-tumor with a RIN score >6 |
| Heart - Colon | ||
| Kidney - Lung | ||
| Human | Colon - Heart | |
| Breast - Vein | ||
Note: The use of samples is included but not limited to the list. Please consult our Customer Technology Advisor if your samples type is not on the list. We cannot accept FFPE samples at this time.
What are the terms and conditions of the project?
- Publications and Promotion: You will be asked to verify on the application landing page that you are willing to co-present your data on two occasions within three months of project completion (excepting data reserved for original content in a peer-reviewed journal).
- Samples: You will be asked to confirm that you can submit the selected gene list and signed BSL form within three weeks of the grant award. You will also need to confirm that your samples will be available for processing within five weeks of the grant award.
- Communication: You will be asked to verify that you will respond to Resolve Biosciences communications, during the grant award and project completion, within three business days.
- If any of the above requirements cannot be met, unless agreed to by both parties, the grant award may be forfeited.
What if I have questions?
For technical questions, please contact Benedikt Nilges, Ph.D. [email protected]
For questions related to Virchow 2.0, please contact the project managers Sonja Hansen and Marie Vidal from the Max Delbrück Center for Molecular Medicine [email protected].
